1794 / 1851
The EXPERT-C trial –
Results
No significant improvement in PFS and OS in the
KRAS/BRAF
WT group (median follow-up 63.8 months)
0
20
40
60
80
100
0
1
2
3
4
5
6
7
8
CAPOX
CAPOX-C
HR 0.62 (0.29-1.35)
p=0.23
Time from randomisation (years)
%
0
20
40
60
80
100
0
1
2
3
4
5
6
7
8
OS
%
HR 0.56 (0.23-1.38)
p=0.20
CAPOX
CAPOX-C
Time from randomisation (years)
PFS